Clinical trial
A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT)
NCT02695771 is registered in ClinicalTrials.gov with Corewell Health West as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT)
- Lead sponsor
- Corewell Health West
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 19, 2016
- Completion date
- October 22, 2021
- Enrollment
- 101 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.